Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELI-TBI
NCT06701760Phase 2Not yet recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2028
- Primary completion
- Dec 2035
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lactated ringer's solution in traumatic brain injury (TBI), sponsored by University of California, Los Angeles. Planned start Jan 2028; status: not yet recruiting.
02
Drugs
lactated ringer's solution
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT06701760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06701760.